Noninvasive, Rapid, and Precise Identification of Esophageal Cancer via Salivary Extracellular Vesicle-Based Diagnosis
ACS Nano · 14.04.2026 · 20 (14) · 11019-11031
DOI: 10.1021/acsnano.5c20621 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 30.03.2026. Verfasst von Liu Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Extracellular Vesicles, Biomarkers, Tumor, Saliva. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Wenzhou Medical University, National Natural Science Foundation of China, Zhejiang Provincial an Ministry of Health Research Fund for Medical Sciences.
Abstract (Originalsprache)
Salivary extracellular vesicles (EVs) have been recognized as one of the most promising noninvasive sources of biomarkers for early cancer detection. However, the lack of efficient isolation and accurate identification methods for salivary EVs limits their clinical utility in early cancer diagnosis. Here, we report the rapid and precise identification of esophageal cancer using the Saliva Extracellular vesicle-based Early Diagnostic system (SEEDx). In this system, salivary EVs were isolated, purified, amplified, and analyzed from human saliva by integrating the ultrafast-isolation platform EXODUS with tandem mass tag (TMT)-based proteomics analysis (EXODUS-TMT proteomics). Using TCGA esophageal cancer (EC) and GTEx healthy population cohorts, we developed a diagnostic model consisting of 9 markers (HIST2H2BE, TP53BP2, TPM4, CALR, HDGF, LMNA, GUSB, NADSYN1, and AGRN), which demonstrated high diagnostic accuracy with AUC values of 0.996 for EC and 0.991 for early-stage EC. We further established a cost-effective model using only two markers (HDGF and CALR) to diagnose both EC and early-stage EC, achieving AUC values of 0.950 and 0.935, respectively. This model was validated in an independent, prospectively collected cohort of EC patients, yielding AUC values of 0.873 and 0.854, respectively. Our streamlined EV isolation and identification workflow facilitates noninvasive biomarker discovery for early-stage esophageal cancer detection. This study extends the EXODUS platform to salivary EVs for EC detection, documents matrix-specific workflow optimizations, and identifies saliva-derived biomarker signatures integrated into a multimarker diagnostic model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
- Eye Hospital, School of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
- School of Biomedical Engineering, Tsinghua Medicine, Tsinghua University, Beijing 100084, China.
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.
- Department of Bioengineering, Department of Electrical Engineering and Computer Science, University of California, Berkeley, Berkeley, California 94720, United States.
- Institute of Quantum Biophysics, Department of Biophysics, Sungkyunkwan University, Suwon 16419, Korea.
ORCID-Profile: Wenpeng Liu, Qingfu Zhu, Tony Y Hu, Luke P Lee, Fei Liu
Förderung
- Wenzhou Medical University
- National Natural Science Foundation of China
- Zhejiang Provincial an Ministry of Health Research Fund for Medical Sciences
Zitieren
APA
Huang, L., Li, M., Liu, W., Lou, D., Zhu, Q., Hu, T. Y., Lee, L. P., & Liu, F. (2026). Noninvasive, Rapid, and Precise Identification of Esophageal Cancer via Salivary Extracellular Vesicle-Based Diagnosis. ACS Nano, 20(14), 11019-11031. https://doi.org/10.1021/acsnano.5c20621
Vancouver
Huang L, Li M, Liu W, Lou D, Zhu Q, Hu TY, et al. Noninvasive, Rapid, and Precise Identification of Esophageal Cancer via Salivary Extracellular Vesicle-Based Diagnosis. ACS Nano. 2026;20(14):11019-11031. doi:10.1021/acsnano.5c20621
BibTeX
@article{Huang2026,
author = {Huang, Liu and Li, Meng and Liu, Wenpeng and Lou, Doudou and Zhu, Qingfu and Hu, Tony Y and Lee, Luke P and Liu, Fei},
title = {Noninvasive, Rapid, and Precise Identification of Esophageal Cancer via Salivary Extracellular Vesicle-Based Diagnosis},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {14},
pages = {11019--11031},
doi = {10.1021/acsnano.5c20621}
}
EUVIMED